Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The acquisition positions Embecta to enter the fast-growing drug-delivery device market and accelerate its shift to a broader medical supplies company. Adds a differentiated drug-delivery platform ...

Shares of Embecta (EMBC) have been trading at multi-year lows as investors fear the overhang of GLP-1 success, with Embecta posting flattish sales at best, yet being able to post strong margins. That ...

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and ...

Welcome, ladies and gentlemen, to Embecta Corp.'s Fiscal Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and a replay will ...

Embecta Corporation () has held its Q1 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off. Unlock hedge fund-level data and powerful invest ...

Embecta Corp. recently reported second-quarter 2026 results showing sales of US$221.8 million and a net loss of US$4.1 million, and also approved a quarterly dividend of US$0.0100 per share payable on ...

It hasn’t even been a year since Becton Dickinson (BD) officially divested with its diabetes care business, Embecta in April 2022. But if you were thinking that would slow this new but old company ...

Embecta Corporation ((EMBC)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to ...

Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based ...